Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brett Dabruzzo"'
Autor:
Richard B. Lipton, Stephanie J. Nahas, Patricia Pozo-Rosich, Tanya Bilchik, Peter McAllister, Michelle Finnegan, Yingyi Liu, Natty Chalermpalanupap, Brett Dabruzzo, David W. Dodick
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Atogepant is an oral calcitonin gene–related peptide receptor antagonist approved for the preventive treatment of migraine in adults. These analyses evaluated the proportions of clinical trial participants who experienced sustai
Externí odkaz:
https://doaj.org/article/476947c9c4ae44f1950aaf9a3c55fac3
Autor:
Paul Rizzoli, Michael J. Marmura, Jennifer Robblee, Jennifer McVige, Sara Sacco, Stephanie J. Nahas, Jessica Ailani, Rosa De Abreu Ferreira, Julia Ma, Jonathan H. Smith, Brett Dabruzzo, Messoud Ashina
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Conventional, non-specific preventive migraine treatments often demonstrate low rates of treatment persistence due to poor efficacy or tolerability. Effective, well-tolerated preventive treatments are needed to reduce migraine sym
Externí odkaz:
https://doaj.org/article/04ca5a47ea8141e181232ded6eeb22d4
Autor:
Andrew M, Blumenfeld, Ramesh, Boinpally, Rosa, De Abreu Ferreira, Joel M, Trugman, Brett, Dabruzzo, Jessica, Ailani, Richard B, Lipton
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:322-332
To evaluate potential drug-drug interactions of ubrogepant and atogepant.Ubrogepant and atogepant, calcitonin gene-related peptide (CGRP) receptor antagonists, are recently approved drugs for acute and preventive treatment of migraine, respectively.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549e1809f1125ec77357581c11ef064c
https://doi.org/10.1111/head.14433
https://doi.org/10.1111/head.14433
Autor:
Stephanie Nahas, Jessica Ailani, Peter McAllister, Rashmi Halker Singh, Richard B. Lipton, Julia Ma, Pranav Gandhi, Jonathan H. Smith, Yingyi Liu, Natty Chalermpalanupap, Brett Dabruzzo
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56bd441035f817de1f6a39eb26cd960d
https://doi.org/10.1212/wnl.0000000000201964
https://doi.org/10.1212/wnl.0000000000201964
Autor:
Patricia Best, Andrea Harriott, Teshamae Monteith, Cristina Tassorelli, Stephanie Nahas, Yingyi Liu, Brett Dabruzzo, Rosa De Abreu Ferreira, Jonathan H. Smith
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dec14aae414b78d7a761397d8a8bd15
https://doi.org/10.1212/wnl.0000000000202040
https://doi.org/10.1212/wnl.0000000000202040
Autor:
Joel M Trugman, Stephen D. Silberstein, Cristina Tassorelli, Michelle Finnegan, Jessica Ailani, Lawrence Severt, Rosa Miceli, Todd J. Schwedt, Richard B. Lipton, Brett Dabruzzo, Kaifeng Lu, Hua Guo
Publikováno v:
Cephalalgia
Background Atogepant is an oral, small-molecule, calcitonin gene–related peptide receptor antagonist for the preventive treatment of migraine. Methods In the double-blind, phase 3 ADVANCE trial, participants with 4–14 migraine days/month were ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e937d6f2cdbc139a04ccbe2ca6992e3
https://doi.org/10.1177/03331024211042385
https://doi.org/10.1177/03331024211042385
Autor:
Richard B. Lipton, Patricia Pozo-Rosich, Andrew M. Blumenfeld, David W. Dodick, Peter McAllister, Ye Li, Kaifeng Lu, Brett Dabruzzo, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M. Trugman
Publikováno v:
Scientia
Migraine; Atogepant; Adults Migraña; Atogepant; Adultos Migranya; Atogepant; Adults Importance Some patients with migraine, particularly those in primary care, require effective, well-tolerated, migraine-specific oral preventive treatments. Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b14b2cfefe2944f20dd328f542a5676
https://pubmed.ncbi.nlm.nih.gov/35675076
https://pubmed.ncbi.nlm.nih.gov/35675076